Barnett, Sam N. https://orcid.org/0000-0002-8968-4319
Cujba, Ana-Maria
Yang, Lu
Maceiras, Ana Raquel https://orcid.org/0000-0001-7045-1331
Li, Shuang
Kedlian, Veronika R.
Pett, J. Patrick https://orcid.org/0000-0002-5249-444X
Polanski, Krzysztof https://orcid.org/0000-0002-2586-9576
Miranda, Antonio M. A. https://orcid.org/0000-0003-4281-614X
Xu, Chuan
Cranley, James
Kanemaru, Kazumasa
Lee, Michael https://orcid.org/0000-0002-0186-4439
Mach, Lukas
Perera, Shani
Tudor, Catherine https://orcid.org/0000-0003-2093-9683
Joseph, Philomeena D.
Pritchard, Sophie
Toscano-Rivalta, Rebecca
Tuong, Zewen K. https://orcid.org/0000-0002-6735-6808
Bolt, Liam https://orcid.org/0000-0001-7293-0774
Petryszak, Robert
Prete, Martin
Cakir, Batuhan https://orcid.org/0000-0003-4513-606X
Huseynov, Alik
Sarropoulos, Ioannis https://orcid.org/0000-0002-2242-0562
Chowdhury, Rasheda A. https://orcid.org/0000-0003-4204-1014
Elmentaite, Rasa
Madissoon, Elo
Oliver, Amanda J. https://orcid.org/0000-0003-1690-9027
Campos, Lia
Brazovskaja, Agnieska https://orcid.org/0000-0001-7298-2072
Gomes, Tomás https://orcid.org/0000-0003-1333-0191
Treutlein, Barbara https://orcid.org/0000-0002-3299-5597
Kim, Chang N. https://orcid.org/0000-0001-7921-4447
Nowakowski, Tomasz J.
Meyer, Kerstin B.
Randi, Anna M.
Noseda, Michela https://orcid.org/0000-0002-9553-5029
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Article History
Received: 16 November 2023
Accepted: 25 October 2024
First Online: 20 November 2024
Competing interests
: In the past 3 years, S.A.T. has consulted for or been a member of scientific advisory boards (SABs) at Qiagen, OMass Therapeutics, Xaira Therapeutics and ForeSite Labs, and a non-executive director of 10x Genomics. She is a co-founder and equity holder of TransitionBio and Ensocell, and a part-time employee at GSK. R.E. is a co-founder and equity holder in Ensocell. The other authors declare no competing interests.